title: Pigmented lichenoid drug eruption: a new clinical presentation of interface dermatitis induced by anti-TNF alpha drugs.
authors.affiliation: Department of Dermatology, Pediatric Dermatology; National Centre for Rare Skin disorders, Hôpital Saint-André, Bordeaux.
authors.forename: Anne Sophie
authors.initials: AS
authors.lastname: Darrigade
authors.affiliation: Department of Pathology, Hôpital Haut-Lévêque, Pessac, France.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Goussot
authors.affiliation: Department of Dermatology, Pediatric Dermatology; National Centre for Rare Skin disorders, Hôpital Saint-André, Bordeaux.
authors.forename: Brigitte
authors.initials: B
authors.lastname: Milpied
authors.affiliation: Department of Dermatology, Pediatric Dermatology; National Centre for Rare Skin disorders, Hôpital Saint-André, Bordeaux.
authors.forename: Alain
authors.initials: A
authors.lastname: Taieb
authors.affiliation: Department of Dermatology, Pediatric Dermatology; National Centre for Rare Skin disorders, Hôpital Saint-André, Bordeaux.
authors.forename: Julien
authors.initials: J
authors.lastname: Seneschal
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D000069285:Infliximab / Q000009:adverse effects*; D017512:Lichenoid Eruptions / Q000139:chemically induced*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab